How Blocking the Inflammatory Effects of C5a In Critically Ill COVID-19 Patients Leads to Survival

This sponsored webinar will provide an overview of the Complement System and C5a Activation, the potential role of C5a in COVID-19 disease progression, and a review of the clinical data for a product recently FDA-authorized for emergency use in critically ill adult patients hospitalized with COVID-19.

No CE credits are offered for this sponsored webinar. Content was determined by the sponsor.

Webinar Sponsor: 

Sepsis Alliance gratefully acknowledges the support provided by InflaRX for this sponsored webinar.